Caeregen wins $1.4M SBIR grant for new eye drug
ROCHESTER–Caeregen Therapeutics announced that it has been awarded a $1.4 million Phase 2 Small Business Innovation Research grant from the National Institutes of Health and its National Eye Institute to …